Načítá se...
Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
Ovarian cancer is most deadly gynecologic malignancies worldwide. Chemotherapy is the mainstay treatment for ovarian cancer. Despite the initial response is promising, frequent recurrence in patients with advanced diseases remains a therapeutic challenge. Thus, understanding the biology of chemoresi...
Uloženo v:
| Vydáno v: | J Gynecol Oncol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5823988/ https://ncbi.nlm.nih.gov/pubmed/29468856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2018.29.e32 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|